Related Experiment Video
Updated: Apr 14, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
8.2K
Computerized touch-panel screening tests for detecting mild cognitive impairment and Alzheimer's disease
Yusuke Fukui1, Toru Yamashita, Nozomi Hishikawa
1Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.
Internal Medicine (Tokyo, Japan)
|April 17, 2015
Summary
A new computerized flipping cards game effectively detects mild cognitive impairment (MCI) in elderly individuals, outperforming traditional tests. This simple screening tool shows promise for early dementia detection in Japan's aging population.
Area of Science:
- Gerontology
- Neuroscience
- Medical Technology
Background:
- Japan faces an increasing elderly population, driving demand for accessible cognitive decline screening.
- Early detection of mild cognitive impairment (MCI) and dementia is crucial for timely intervention.
Purpose of the Study:
- To evaluate the efficacy of computerized touch-panel screening tests for detecting cognitive and affective declines.
- To compare these novel tests against conventional assessments in identifying MCI and Alzheimer's disease (AD).
Main Methods:
- 41 MCI subjects, 124 AD patients, and 75 controls underwent cognitive/affective assessments and four computerized touch-panel tests.
- Performance on computerized games and traditional cognitive/affective measures was analyzed.
Main Results:
- Computerized games differentiated AD patients from controls (p<0.01).
- The flipping cards game distinguished MCI subjects from controls (30.9 ± 18.4 sec vs. 19.3 ± 9.5 sec, p<0.01).
- Affective assessments (ABS, AS) also differentiated MCI from controls.
Conclusions:
- Computerized touch-panel tests effectively identified AD patients.
- The flipping cards game demonstrated superior sensitivity in detecting MCI compared to conventional methods.
- This novel touch-panel test offers a promising, sensitive tool for early MCI detection in the elderly.
Related Concept Videos
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:30Dementia
728
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
728